Comparison of in vitro Resistance of Wild Leishmania İsolates, Which are Resistant to Pentavalent Antimonial Compounds, Against Drugs Used in the Treatment of Leishmaniasis

Comparison of in vitro Resistance of Wild Leishmania İsolates, Which are Resistant to Pentavalent Antimonial Compounds, Against Drugs Used in the Treatment of Leishmaniasis

Objective:Meglumine antimoniate (Glucantime®) and Sodium stibogluconate (Pentostam®) are used for the treatment of cutaneous leismaniasis in Turkey. There is a reported resistance to these drugs in recent years. The aim of the present study was to compare the in vitro sensitivities of resistant Leis...

Full description

Bibliographic Details
Main Authors:	Ahmet Özbilgin, İbrahim Çavuş, Tuğba Kaya, Ahmet Yıldırım, Mehmet Harman
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2020-03-01
Series:	Türkiye Parazitoloji Dergisi
Subjects:	cutaneous leishmaniasis resistance treatment resistance tests turkey
Online Access:	http://www.turkiyeparazitolderg.org/archives/archive-detail/article-preview/comparison-of-iin-vitro-i-resistance-of-wild-ileis/36525

Similar Items

Investigation of in vitro Efficacy of Miltefosine on Chronic Cutaneous Leishmaniasis
by: Varol Tunalı, et al.
Published: (2022-06-01)

In Vitro Reduced Susceptibility to Pentavalent Antimonials of a <i>Leishmania infantum</i> Isolate from a Human Cutaneous Leishmaniasis Case in Central Italy
by: Aurora Diotallevi, et al.
Published: (2021-05-01)

Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine
by: A.L.P. Ribeiro, et al.
Published: (1999-03-01)

Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine
by: Ribeiro A.L.P., et al.
Published: (1999-01-01)

Leishmaniasis in Turkey: Determination of Leishmania Species by Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF MS)
by: Gülnaz Culha, et al.
Published: (2014-06-01)

Could RPMI-1640 Medium be Used in the Diagnosis and Isolation of Cutaneous Leishmaniasis Lacking NNN Medium?
by: İbrahim Çavuş, et al.
Published: (2022-09-01)

Review of the prevalence and causes of antimony compounds resistance in different societies review article
by: Fariba Jaffary, et al.
Published: (2017-09-01)

Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial
by: Oliveira Rodrigo A, et al.
Published: (2012-06-01)

A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis
by: Sofia Sales Martins, et al.
Published: (2021-07-01)

American tegumentary leishmaniasis: severe side effects of pentavalent antimonial in a patient with chronic renal failure
by: Sílvio Alencar Marques, et al.
Published: (2019-07-01)

Increased thiol levels in antimony-resistant Leishmania infantum isolated from treatment-refractory visceral leishmaniasis in Brazil
by: Lucas S Magalhães, et al.

Cutaneous leishmaniasis in cats (Felis domesticus) caused by Leishmania (Leishmania) venezuelensis
by: Rafael Bonfante Garrido, et al.
Published: (2010-07-01)

Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis
by: Santos Mácia A., et al.
Published: (2002-01-01)

Aquaglyceroporin1 gene expression in antimony resistance and susceptible Leishmania major isolates
by: Gilda Eslami, et al.
Published: (2016-01-01)

Drug resistance in leishmaniasis
by: Jaya Chakravarty, et al.
Published: (2010-01-01)

Knock, knock, knocking on Europe’s door: Threat of leishmaniasis in Europe with a focus on Turkey
by: Varol Tunalı, et al.
Published: (2023-01-01)

Antimonial treatment failure rate in patients with cutaneous leishmaniasis
by: Fariba Jaffary, et al.
Published: (2018-06-01)

Treatment of cutaneous leishmaniasis with combination of allopurinol and low dose of meglumine antimoniate
by: A Momeni, et al.
Published: (2001-03-01)

Antimony resistance and gene expression in Leishmania: spotlight on molecular and proteomic aspects
by: Rajamanthrilage Kasun Madusanka, et al.
Published: (2024-01-01)

Leishmania tropica infection in wild and domestic canines
by: G Baneth, et al.
Published: (2014-04-01)

Estudo comparativo entre miltefosina oral e antimoniato de N-metil glucamina parenteral no tratamento da leishmaniose experimental causada por Leishmania (Leishmania) amazonensis Comparative study between oral miltefosine and parenteral N-metil glucamine antimoniate for the treatment of experimental leishmaniasis caused Leishmania (Leishmania) amazonensis
by: Arnoldo Velloso da Costa Filho, et al.
Published: (2008-08-01)

Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy
by: Sandip Mukherjee, et al.
Published: (2020-11-01)

Cutaneous Leishmaniasis Caused by an Unknown Leishmania Strain, Arizona, USA
by: Marcos de Almeida, et al.
Published: (2021-06-01)

Evaluating the Glucantime Concentration for the ex vivo Glial Cell Model of Antimony-resistant Leishmania tropica Amastigotes
by: Orçun Zorbozan, et al.
Published: (2021-12-01)

Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
by: Deninson Alejandro Vargas, et al.
Published: (2019-06-01)

Cutaneous sporotrichoid leishmaniasis: An atypical case caused by Leishmania major
by: Adila Bassaid, et al.
Published: (2022-01-01)

In Vitro Study of Leishmanicidal Activity of Biogenic Selenium Nanoparticles against Iranian Isolate of Sensitive and Glucantime-Resistant Leishmania tropica
by: Hossein Mahmoudvand, et al.
Published: (2014-12-01)

Disseminated Leishmaniasis, a Severe Form of Leishmania Braziliensis Infection
by: Paulo R.L. Machado, et al.
Published: (2024-03-01)

Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel
by: Michal Solomon, et al.
Published: (2019-04-01)

Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis
by: Maria Cristina de Oliveira Duque, et al.

Active cutaneous leishmaniasis in Brazil, induced by Leishmania donovani chagasi
by: M. P. Oliveira Neto, et al.
Published: (1986-09-01)

Isolation and Molecular Identification of Leishmania spp. Agents in Patients with Cutaneous Leishmaniasis in Yazd Province, Endemic Region of Central Iran
by: Gilda ESLAMI, et al.
Published: (2020-05-01)

ELECTROCARDIOGRAPHIC CHANGES WITH STANDARD DOSE OF MEGLUMINE ANTIMONIATE THERAPY IN CUTANEOUS LEISHMANIASIS
by: Moizza Tahir, et al.
Published: (2021-08-01)

Leishmaniose cutânea com desfecho fatal durante tratamento com antimonial pentavalente American cutaneous leishmaniasis with fatal outcome during pentavalent antimoniate treatment
by: Meiri Vanderlei Nogueira de Lima, et al.
Published: (2007-06-01)

High and low doses of antimony (Sb v) in American cutaneous leishmaniasis: a five years follow-up study of 15 patients
by: MP Oliveira-Neto, et al.
Published: (1996-04-01)

Pentavalent Antimonials: New Perspectives for Old Drugs
by: Raul R. Ribeiro, et al.
Published: (2009-06-01)

The Extraordinary Case of a Woman with a 30-Year-Long Diffuse Leishmaniasis Cured with One Single Ampoule of Intranasal Pentavalent Antimoniate
by: Sheila V. C. B. Gonçalves, et al.
Published: (2023-06-01)

Diagnosis and Molecular Typing of Leishmania in Patients with Cutaneous Leishmaniasis
by: Alisha Akia, et al.
Published: (2017-03-01)

High Selectivity of 8-Hydroxyquinoline on <i>Leishmania (Leishmania)</i> and <i>Leishmania (Viannia)</i> Species Correlates with a Potent Therapeutic Activity In Vivo
by: Sarah Kymberly Santos de Lima, et al.
Published: (2023-05-01)

Comparison of the specificity of PCR and the histopathological detection of leishmania for the diagnosis of American cutaneous leishmaniasis
by: A.C.R. Medeiros, et al.
Published: (2002-04-01)